BRCA1 and ovarian carcinoma: BRCA-1 and BRCA-2 mutation carriers often participate in a surveillance programme for early detection of ovarian cancer consisting of annual pelvic examination and transvaginal ultrasound (TVU) combined with serum CA-125 assessment.